MENARINI SILICON BIOSYSTEMS
CELLSEARCH® is the first and only clinically validated blood test cleared by the FDA for detecting and counting Circulating Tumor Cells (CTCs) to aid in managing patients with metastatic breast, prostate, and colorectal cancers when used in conjunction with other clinical methods (for full intended use see documents.cellsearchctc.com)
DEPArray™ PLUS (for Research Use Only) is an image-based digital cell-sorting and isolation platform, with 9 fluorescent channels and high level of automation, that enables clinical researchers to study rare cells with single-cell precision.
The integration of CELLSEARCH® and DEPArray™ technologies provide an end-to-end workflow solution for the enumeration, isolation, and molecular characterization of CTCs in liquid biopsy.
Menarini Silicon Biosystems, based in Italy, and USA is a wholly owned subsidiary of the Menarini Group.